We can’t show the full text here under this license. Use the link below to read it at the source.
Exosomes in Disease Therapy: Plant-Derived Exosome-Like Nanoparticles Current Status, Challenges, and Future Prospects
Plant-Based Tiny Particles for Treating Diseases: Current Use, Challenges, and Future Possibilities
AI simplified
Abstract
(PLNs) offer a novel, biocompatible alternative for drug delivery.
- PLNs are derived from edible plants and medicinal herbs, featuring low and enhanced safety.
- They can cross biological barriers and carry bioactive molecules, making them suitable for targeted delivery.
- Experimental data reveals PLNs' potential therapeutic applications in oncology, immunotherapy, regenerative medicine, and gene therapy.
- Challenges include stability, regulatory standards, and delivery specificity that may hinder clinical translation.
- Technological advancements are necessary for the engineering, isolation, and manufacturing of PLNs.
AI simplified
Key numbers
60–80%
Reduction
exhibit lower than mammalian .
over 400
Encapsulation of Bioactive Compounds
Distinct miRNAs identified across 11 plant species.